The Place of Consultations Specializing in the Diagnosis of Mood Disorders in Strasbourg University Hospital

NCT ID: NCT05145790

Last Updated: 2021-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

197 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-15

Study Completion Date

2022-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mood disorders (depressive disorders and bipolar disorders) are among the ten most worrying diseases of the 21st century according to the WHO.

In order to support psychiatrists in their diagnostic reflection, structures have been created. Since 2009, the Psychiatry Service 2 within the Psychiatry, Mental Health and Addictology Pole of the University Hospitals of Strasbourg has offered specialized consultations in mood disorders.

More than 10 years after the creation of these consultations, it seems interesting to study the profile of the users and to describe the nature of the reports of these in-depth evaluation consultations (diagnosis, therapeutic advice)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mood Disorders

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Mood Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major subject
* Specialized primary consultation highlighting symptoms of mood disorders with Prof. Berstchy in the psychiatry department 2 in the University Hospital of Strasbourg (patients whose consultation request was linked to symptoms or a diagnosis of ADHD will not be included in the study population).
* Consultation that took place in 2018 and 2019.
* Patient who did not express his opposition to the reuse of his data for scientific research purposes.

Exclusion Criteria

* Patient opposition to the use of their personal data for scientific research purposes.
* Prior existence of a previous specialist consultation in mood disorders with Prof. Berstchy (the information collected during the first consultation is not accessible)
* Patient under curatorship, guardianship or legal protection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gilles BERTSCHY, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gilles BERTSCHY, MD, PhD

Role: CONTACT

Phone: 33 3 88 11 65 48

Email: [email protected]

Saïd CHAYER, PhD, HDR

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gilles BERTSCHY, MD, PhD

Role: primary

Saïd CHAYER, PhD, HDR

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8365

Identifier Type: -

Identifier Source: org_study_id